Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,359,470 | -22.1% | 249,444 | -3.0% | 0.00% | – |
Q2 2023 | $1,745,675 | +47.9% | 257,095 | +9.1% | 0.00% | – |
Q1 2023 | $1,180,556 | -3.8% | 235,640 | -6.3% | 0.00% | – |
Q4 2022 | $1,227,608 | -65.7% | 251,559 | +1.3% | 0.00% | -100.0% |
Q3 2022 | $3,583,000 | -4.4% | 248,415 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $3,747,000 | +34.9% | 247,608 | +5.9% | 0.00% | 0.0% |
Q1 2022 | $2,778,000 | -30.0% | 233,756 | -4.5% | 0.00% | 0.0% |
Q4 2021 | $3,968,000 | -42.0% | 244,744 | +2.1% | 0.00% | -50.0% |
Q3 2021 | $6,839,000 | +0.1% | 239,619 | +18.6% | 0.00% | 0.0% |
Q2 2021 | $6,832,000 | +18.6% | 202,119 | +6.1% | 0.00% | 0.0% |
Q1 2021 | $5,762,000 | -34.4% | 190,518 | +7.3% | 0.00% | -33.3% |
Q4 2020 | $8,787,000 | +32.9% | 177,476 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $6,613,000 | +8.6% | 172,240 | +22.3% | 0.00% | 0.0% |
Q2 2020 | $6,087,000 | +93.0% | 140,881 | +16.6% | 0.00% | +50.0% |
Q1 2020 | $3,154,000 | -14.8% | 120,808 | +1.9% | 0.00% | 0.0% |
Q4 2019 | $3,704,000 | +63.0% | 118,528 | +36.0% | 0.00% | +100.0% |
Q3 2019 | $2,272,000 | +50.5% | 87,154 | +32.0% | 0.00% | 0.0% |
Q2 2019 | $1,510,000 | +61.2% | 66,001 | +84.7% | 0.00% | 0.0% |
Q1 2019 | $937,000 | +23.1% | 35,733 | -4.4% | 0.00% | 0.0% |
Q4 2018 | $761,000 | – | 37,382 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
Caligan Partners LP | 23,321 | $127,099 | 0.06% |
Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |